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For assessment of genetic association between single-nucleotide polymorphisms (SNPs) and disease status, the logistic-regression model
or generalized linear model is typically employed. However, testing for deviation from Hardy-Weinberg proportion in a patient group
could be another approach for genetic-association studies. The Hardy-Weinberg proportion is one of the most important principles
in population genetics. Deviation from Hardy-Weinberg proportion among cases (patients) could provide additional evidence for the
association between SNPs and diseases. To develop a more powerful statistical test for genetic-association studies, we combined evidence
about deviation fromHardy-Weinberg proportion in case subjects and standard regression approaches that use case and control subjects.
In this paper, we propose two approaches for combining such information: the mean-based tail-strengthmeasure and themedian-based
tail-strength measure. These measures integrate logistic regression and Hardy-Weinberg-proportion tests for the study of the association
between a binary disease outcome and an SNP on the basis of case- and control-subject data. For bothmean-based andmedian-based tail-
strengthmeasures, we derived exact formulas to compute p values.We also developed an approach for obtaining empirical p values with
the use of a resampling procedure. Results from simulation studies and real-disease studies demonstrate that the proposed approach is
more powerful than the traditional logistic-regression model. The type I error probabilities of our approach were also well controlled.Introduction
Traditionally, regression approaches have been used for
the assessment of the genetic association between sin-
gle-nucleotide polymorphisms (SNPs) and disease status
and have been applied to detect a variety of disease-caus-
ing SNPs.1–8 However, the regression approaches do not
integrate information that is available from other sour-
ces, such as deviation from Hardy-Weinberg (hereafter,
HW) proportion in cases. Therefore, we propose an ap-
proach for gene-association assessment that integrates
the HW-proportion information in the regression ap-
proaches.
The HW proportion is one of the most important princi-
ples in population genetics. Consider a simple case with
two alleles, A and a, at a single locus. If the allele frequency
of A is denoted as p, then the frequency of a is (1  p). Un-
der the assumption of HW proportion in the population,
the frequencies of three possible genotypes, (A, A), (A, a),
and (a, a), are the products of allele frequencies p2,
2p(1  p), and (1  p)2, respectively.
In case-control association studies, the HW proportion
assessed in control subjects is widely used as a quality-con-
trol tool for identifying genotyping errors.9–12 However,
researchers also suggest that deviation from HW propor-
tion—which can be evaluated via a comparison of the
difference between observed genotype frequencies and
the corresponding expected frequencies 13—among cases
(patients) can provide additional evidence for a real associ-
ation between SNP genotypes and disease outcomes.14–18
Thus, testing for deviation from HW proportion could be
another approach for the study of genetic association.1Department of Epidemiology, M. D. Anderson Cancer Center, University of
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DOI 10.1016/j.ajhg.2008.06.010. ª2008 by The American Society of HumanTo develop a more powerful statistical test for genetic as-
sociation, we combined evidence from HW-proportion de-
viation and from regression approaches to perform the
case-control association study. A mean-based tail-strength
(TS) measure for association study is proposed, in which
we have combined two different hypothesis tests, (1) the
logistic-regression model and (2) the test for deviation
from HW proportion in case subjects. Although these
two hypothesis tests are quite different, given that they
use different test statistics and test different aspects of
the dataset, both tests can provide information about the
association between SNPs and diseases. These two tests
are also statistically correlated. Both cases and controls
are used in logistic regression, whereas the HW-proportion
test, as proposed, uses data from cases only. The proposed
mean-based TSmeasure allows dependence between these
two tests. We further extended the mean-based TSmeasure
to a median-based TS (TSM) measure by using median
values instead of expected values. For both measures, we
derived the exact formulas for calculation of p values. We
also propose an approach for estimating empirical p values
with the use of a resampling procedure.
On the basis of the exact and empirical results from sim-
ulated data and real biological examples, our proposed ap-
proach is more powerful than the traditional association
study approaches, achieving higher power than that
achieved by each individual test and maintaining good
control over type I error probabilities. This combined ap-
proach is also valid for performing association studies
with the use of other statistical methods, including piece-
wise logistic regression, nonparametric logistic regression,
and functional logistic regression.Texas, Houston, TX 77030, USA
Genetics. All rights reserved.
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Material and Methods
For simplicity, we assume two alleles, A and a, at a locus, with A as
the deleterious allele and a as the normal allele. We use a categori-
cal random variable, X ¼ {0, 1, 2}, to denote the three genotypes,
(A, A), (A, a), and (a, a). Note that the values of the random vari-
able correspond to the number of copies of the A allele. This cod-
ing assumes an additive model, but different coding for represent-
ing a dominant or recessive model can also be used. Our proposed
approach is not restricted to an additive model. We deﬁned an-
other categorical random variable, Y ¼ {0,1}, to indicate the case-
control status, with 0 representing individuals in the control
group and 1 representing individuals in the case group.
Given a dataset of observations of random variables X and Y
corresponding to the genotypes of a SNP and the case-control out-
comes, respectively, two hypothesis tests can be applied for
detection of the association between disease and SNP: the logis-
tic-regression approach, using cases and controls, and the test
for deviation from HW proportion among cases. Our goal was to
combine these two tests to achieve a more powerful statistical
test for association study.
Tail-Strength Measures
A tail-strength (TS) measure was recently developed by Taylor and
Tibshirani19 for the study of large amounts of microarray data.
This measure assesses the overall univariate strength of a large
set of features in microarray and other genomic studies. We ap-
plied and extended the TS measure to the problem of integrating
the logistic-regression association approach and the test for devia-
tion from HW proportion, as brieﬂy described below.
Considerm p values pi, i ¼ 1,.m, with respect to them null hy-
potheses. The global hypothesis is that all the individual hypoth-
eses hold simultaneously. Now denote p(1) % p(2) % .p(m) as the
ordered p values. Thus, the TS measure is deﬁned as follows:
TS

p1, p2,.pm
 ¼ 1
m
Xm
i¼1

1 pðiÞmþ 1
i

: (1)
Note that under the null hypothesis, each pi has uniform distri-
bution, so that the ordered p value p(i) follows a beta distribution
with the mean as i/(m þ 1). Hence, the test statistic TS has an ex-
pectation of zero under the null hypothesis. Taylor and Tibshirani
showed in their paper that the TSmeasure is closely related to the
false-discovery rate (FDR) approach to multiple-hypothesis test-
ing. From this property, they derived the asymptotic distribution
for TS when m is large, which is normally distributed with
a mean of 0 and a variance of 1/m. They also showed that the TS
measure has a close relationship to a weighted area under a
receiver operating characteristic (ROC) curve.
The TS measure calculates the linear combination of the differ-
ence between each p value and its expected value. In this form, as
Equation (1), it gives more weight to the smaller p values so that it
is more sensitive to deviations in the tail. When the TS value
approaches 1, it shows that there are more small p values than
we would expect by chance and then indicates the evidence
against the global-null hypothesis.19 In this way, we would expect
that the test statistic TS for the global hypothesis should be more
powerful than each individual test.
In our speciﬁc problem, the asymptotic distribution of TS can-
not be applied. Recall that we now consider two hypothesis tests,
which are correlated. We are proposing to use the TS measure for
combining the logistic-regression association model that uses54 The American Journal of Human Genetics 83, 53–63, July 2008cases and controls for testing H01 (H01: Association does not exist
between SNP and disease) with evidence derived from the Hardy-
Weinberg proportion test for testing H02 (H02: HW proportion
exists among case subjects).
Consider a single SNP, X. Recall that Y is the random variable
corresponding to the outcomes of the disease of concern. Let T1
be the test statistic for using the logistic regressionmodel to detect
the association between X and Y (i.e., H01) and T2 be the test sta-
tistic for testing deviation from the HW proportion among cases
(i.e., H02). In our proposal, we used the likelihood-ratio test for lo-
gistic regression and performed the exact test for testing HW-pro-
portion deviation in the case group.13,20,21 Let p1 and p2 be the
p values that correspond to T1 and T2. Accordingly, p(1) and p(2)
are the ordered p values. Therefore, we can deﬁne the tail-strength
measure that combines the two p values as follows:
TSðp1, p2Þ ¼ 1
2

1 pð1Þ33

þ

1 pð2Þ33
2

(2)
to test the global-null hypothesis that the SNP is not associated
with disease.
The domain of random variable TS is [1.25, 1], given that 0%
p(1) % p(2) % 1. Recall that p(1) and p(2) follow a beta distribution
under the null hypothesis. Using a bivariate transformation, we
can derive the explicit formula for the probability-density func-
tion of the tail-strength random variable TS:
fTSðxÞ ¼
8
27

5
2
þ 2x

, if x˛½ 1:25, 0:25,
32
27
ð1 xÞ, if x˛ð0:25, 1:
8><
>: (3)
Given an observation of TS*, the exact p values of random
variable TS can be calculated by a simple integral of the above
equation such that
p value ¼ PðTS > TSÞ ¼
ð1
TS
fTSðxÞdx (4)
TS is a measure that uses means for comparison with observed
p values. But in some situations, median-based estimators are
more robust for extreme observations. Because we are dealing
with small p values, a median-based tail-strength measure might
be more appropriate under some circumstances, whereas a mean-
basedmeasuremight apply to other situations. Therefore,we devel-
oped a measure for the assessment of tail strength with the use of
median values. We call it the tail-strength median (TSM) measure,
in which the linear combination of the difference between p values
and corresponding median values, rather than expected values, is
calculated under the null hypothesis. The median values for p(1)
and p(2) are 1 1=
ﬃﬃﬃ
2
p
and 1=
ﬃﬃﬃ
2
p
, respectively. Therefore, the TSM
measure can be deﬁned as
TSMðp1, p2Þ ¼ 1
2
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for testing the global-null hypothesis for the association between
the SNP and the disease in question.
We derived the explicit form for the probability-density func-
tion of the tail-strength-median random variable TSM. In this
situation, the domain of the random variable is ½ ﬃﬃﬃ2p , 1.
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Given an observation of TSM*, the exact p values of random
variable TSM can be calculated by a simple integral of the above
equation, such that
p value ¼ PðTSM > TSMÞ ¼
ð1
TSM
gTSMðxÞdx (7)
Compared with TS, TSM assigns evenmore weight to the smaller p
values but less weight to the bigger p values. Note that the FDR
approach can be explained as a procedure in which ordered p
values are compared with the functions of their expected values.22
Using similar thinking, we now consider median values of ordered
p values instead of expected p values. Consequently, the TSMmea-
sure also has a close relationship to the FDR approach to multiple-
hypothesis testing. (The derivations for the explicit forms of den-
sity functions of TS and TSM and associated p values are given in
Appendix 1.)
Permutation Tests
Although the exact p values of TS and TSM are simple and straight-
forward to compute and interpret, the derivations of underlying
assumptions might make the exact p values based on the explicit
formulas either too conservative or too liberal. Therefore, we also
proposed an approach for estimating empirical p values of TS and
TSM with the use of a permutation procedure. For each permuta-
tion step, we resample the SNP-values vector by using the geno-
type frequencies calculated from the allele frequencies of the
whole dataset, including the SNP values in both case and control
groups, but keep all the other random-variable vectors (e.g., cova-
riates) unchanged. By resampling the SNP values, we ensure that
there will be no association between the outcomes and the SNP.
The empirical p values for both tests are estimated by the propor-
tion of TS or TSM values resulting from permutations that are
greater than the observed TS or TSM values. The performance of
the permutation tests is evaluated in Appendix 2.
Simulation Studies
We examined the performance of the proposed approach by per-
forming simulation studies ﬁrst and then applying the approach
to real diseases. In order to simulate data related to the genotypes
of SNPs and the outcomes of case-control status, two logistic
models were used. In the ﬁrst simulated model, we considered
only SNPs as the risk factors associated with diseases and speciﬁed
the frequencies of genotypes and the odds ratios (ORs) of the logis-
tic model. We performed further simulation studies based on a real
disease (lung cancer) model, involving SNPs and other statistically
signiﬁcant risk factors. The second simulated model was based on
a lung-cancer study of current smokers.23We studied different pre-
deﬁned genotype frequencies and ORs of SNPs while citing those
of all the other risk factors from the literature. In the following
Table 1. Simulation Parameters for Data Sets Generated
from Model 1
Data Set b0 b1 b2 SNP 2
Data 1 2.0 0.3 (OR ¼ 1.35) 1.0 3 1010 (OR ¼ 1) Observed
Data 2 2.0 0.3 (OR ¼ 1.35) 1.0 3 1010 (OR ¼ 1) Unobserved
Data 3 2.0 0.3 (OR ¼ 1.35) 0.3 (OR ¼ 1.35) Observed
Data 4 2.0 0.3 (OR ¼ 1.35) 0.3 (OR ¼ 1.35) Unobserved
Data 5 2.0 0.5 (OR ¼ 1.65) 0.3 (OR ¼ 1.35) Observed
Data 6 2.0 0.5 (OR ¼ 1.65) 0.3 (OR ¼ 1.35) Unobservedsections, we describe the models for these simulation studies and
report the results accordingly.
Model 1
Considering two independent SNPs at two different genetic loci,
X1 and X2, we deﬁned the corresponding logistic model of the
association between SNPs and case-control outcomes as
Logit ðPðY ¼ 1ÞÞ ¼ b0 þ b1X1 þ b2X2
First, we simulated genotypes of X1 andX2 under the null hypoth-
esis—that is, under the assumption of HW proportion in the
general population. In this model, unless otherwise speciﬁed, we
assumed minor-allele frequencies of 10% for SNP X1 and 40%
for SNP X2. Given the dataset of realizations of SNPs X1 and X2,
one could randomly generate disease status for each individual ac-
cording to the logistic model above. In this way, we simulated
a large amount of data on the population of interest, then ran-
domly sampled 500 disease-related cases along with 500 normal
controls from the population, with the assumption of an alterna-
tive global hypothesis. Note that we assumed HW proportion in
the general population; however, after simulation, cases might
not be in HW proportion. Thus, given the data set simulated
from the above model, we could evaluate the performance of the
TS measure and the TSM measure proposed to combine the two
hypothesis tests.
We generated six datasets fromModel 1, with different ORs asso-
ciatedwith SNPX1, while either observing or not observing the sec-
ond SNP,X2. The speciﬁc parameters for different datasets are given
inTable 1. b0 remainedﬁxed in all the datasets. TwoORs for SNPX1,
OR¼ 1.35 and OR ¼ 1.65, were studied. According to Table 1, SNP
X2 could be insigniﬁcantly associated with disease (OR ¼ 1) and
observed (genotyped), insigniﬁcantly associated with disease and
unobserved, signiﬁcantly associated with disease (OR ¼ 1.35) and
observed, or signiﬁcantly associated with disease (OR ¼ 1.35) but
unobserved. For example, Data set 3 was generated at b0 ¼ 2,
b1¼ 0.3, and b2¼ 0.3, and SNPX2 was observed. Averages of signi-
ﬁcance reported in the Results section are based on 100 replicates,
which included 500 cases and 500 controls. The signiﬁcance of
each replicatewas determined by both exact p values and empirical
p values derived from the permutation tests described above.
Model 2
We simulated data from a lung-cancermodel based on the study of
Spitz et al.,23 as shown in Table 2. All the statistically signiﬁcant
risk factors associated with lung cancer among current smokers
are listed, including a history of emphysema, exposure to dust, ex-
posure to asbestos, family history of any cancer, a history of hay
fever, and smoking intensity (pack-years), with the cut points
Table 2. Lung-Cancer Models
Risk Factors Coefficients of Logistic Model Prevalence
Intercept 0.7173
SNP 0.3 (OR ¼ 1.35)/0.5 (OR ¼ 1.65)
Smoking 2.3 (OR ¼ 9.97)/0.0 (OR ¼ 1) 21.0%
Emphysema 0.7561 (OR ¼ 2.13) 35.0%
Dust exposure 0.3067 (OR ¼ 1.36) 21.0%
Asbestos exposure 0.4109 (OR ¼ 1.51) 23.7%
Family history 0.3859 (OR ¼ 1.47) 7.1%
Hay fever 0.4047 (OR ¼ 1.50) 9.0%
Pack-years
28-41.9 0.2219 (OR ¼ 1.25) 25.0%
42-57.4 0.3747 (OR ¼ 1.45) 25.0%
R57.5 0.6151 (OR ¼ 1.85) 25.0%The American Journal of Human Genetics 83, 53–63, July 2008 55
Table 3. Average p Values from Different Tests in Simulations for Model 1
Data Set p-logita p-HWPb
TS TSM
Empirical TS p Values Exact TS p Values Empirical TSM p Values Exact TSM p Values
Data 1 0.0099 0.0264 0.0006 0.0009 0.0006 0.0009
Data 2 0.0135 0.0257 0.0007 0.0010 0.0008 0.0011
Data 3 0.0130 0.0288 0.0008 0.0012 0.0009 0.0013
Data 4 0.0147 0.0254 0.0009 0.0012 0.0009 0.0013
Data 5 0.0044 0.0261 0.0004 0.0006 0.0004 0.0006
Data 6 0.0041 0.0246 0.0004 0.0005 0.0004 0.0006
a p value from logistic-regression test.
b p value from HW-proportion test.based on the quartile of current smoker pack-years in control sub-
jects. For the purpose of our study, two more factors were consid-
ered: smoking status and existence of a single SNP.We deﬁned two
models with respect to smoking status. The two lung-cancer
models correspond to two groups of people: the general lung-can-
cer population and the current-smoker lung-cancer population.
We, therefore, refer to them as the ‘‘general model’’ and the
‘‘current-smoker model.’’ When we only considered the current-
smoker lung-cancer population, we removed the smoking risk
factor from the logistic model; when we studied the whole popu-
lation, smoking status was included and was an extremely signi-
ﬁcant variable in the model.24
For the purpose of simulation, all the ORs of the risk factors, ex-
cept SNP, were from the Spitz et al. study.23 The prevalences of the
risk factors cited came from different papers or statistical summa-
ries: smoking,23 history of emphysema,25 exposure to dust,26 ex-
posure to asbestos,27 family history of any cancer,28 and history
of hay fever.25 Table 2 lists the parameters that we used to simulate
the data according to the model described above. For example, the
OR for a history of emphysema was 2.13, and its prevalence was
set to 35%. The OR for smoking status was deﬁned as 1 in the
current-smoker model and as approximately 10 in the general
model, because smoking is the most signiﬁcant risk factor for lung
cancer.
In the lung-cancer models, we wanted to demonstrate the per-
formance of our approach for SNP association with different logis-
tic coefﬁcients (ORs) and different genotype frequencies. There-
fore, for each model, we generated six datasets with respect to
different ORs of the SNP, as well as different genotype frequencies,
on the basis of the ORs and prevalences listed in Table 2 for all the
other risk factors for lung cancer. We exclusively studied two ORs
for the SNP, OR ¼ 1.35 and OR ¼ 1.65, as in Model 1. For each OR,
we usedminor-allele frequencies of 10%, 30%, and 50% (from rare
to more common).We used the same approach for simulation and
the assumption of the alternative hypothesis used in Model 1, and
100 replicates were generated for each scenario, including 500
cases and 500 controls in each replicate. The signiﬁcance of each
replicate was also determined by both exact p values and empirical
p values.
Type I Error Estimate
We performed additional simulations to examine the type I error
probability of our approach under the global-null hypothesis of
no association between the SNP and the disease. For both simula-
tion Model 1 and Model 2, we used the same settings as above, ex-
cept that the coefﬁcient of SNP for the logistic model was set to
zero (OR ¼ 1). We generated four datasets from Model 1, which56 The American Journal of Human Genetics 83, 53–63, July 2008correspond to data sets 1–4 in Table 1, except that b1 ¼ 0 (data
sets 5 and 6 are exactly the same as Data sets 3 and 4 under the
null hypothesis). To test Model 2, we generated three datasets
from the general model with respect to different genotype fre-
quencies, along with three datasets from the current-smoker
model. For each conﬁguration, 10,000 simulated replicates were
generated, each with 500 cases and 500 controls.
Results
Model 1
All of the resulting logistic-regression p values, HW-propor-
tion test p values, empirical p values of TS and TSM, and ex-
act p values of TS and TSM are reported in Table 3. For all
tests, we reported the average results, grouped with respect
to TS and TSM. For instance, for data set 3 (generated with
b0 ¼ 2.0, b1 ¼ 0.3, and b2 ¼ 0.3, and in which SNP X2
was observed; see Table 1), on the basis of 100 replicates,
the average p value obtained from logistic regression with
the use of cases and controls was 0.013, whereas the average
p value from the HW-proportion test in the case group was
0.0288.After applying theTSmeasure andtheTSMmeasure,
the average empirical p values from 100,000 permutations
were 0.0008 and 0.0009 for TS and TSM, respectively, and
the average exact p values calculated from Equations (4)
and (7)were 0.0012 and0.0013 forTS andTSM, respectively.
We obtained more signiﬁcant p values by using both TS
and TSM measures as compared with those obtained with
the use of logistic regression. When the SNP X2 was signif-
icantly associated with the disease, whether or not we
could observe the values of SNP X2, we obtained nearly
identical exact and empirical p values for both measures
(see results for data sets 3–6 from Table 3). The empirical
and exact p values were very similar, but the empirical ap-
proach yielded slightly more liberal p values, possibly be-
cause we used 100,000 permutations. However, the exact
p values were still satisfactory in this situation, because
they are computationally more practical than the use of
permutation tests.
Because all the replicates in each dataset were simulated
under the alternative hypothesis, we examined the statisti-
cal power of our approach. Table 4 shows the observed
power based on 100 replicates for the six data sets (for
which average p values are reported in Table 3) at the
Table 4. Power Comparison at 0.01, 0.005, and 0.001 Significance Levels in Simulations for Model 1
Power for Logistic Model
Power for TS Power for TSM
Empirical Powers Exact Powers Empirical powers Exact powers
Data Set 0.01 0.005 0.001 0.01 0.005 0.001 0.01 0.005 0.001 0.01 0.005 0.001 0.01 0.005 0.001
Data 1 0.67 0.54 0.26 1.00 1.00 0.80 1.00 1.00 0.73 1.00 1.00 0.81 1.00 0.99 0.73
Data 2 0.51 0.32 0.16 1.00 1.00 0.80 1.00 0.98 0.63 1.00 0.99 0.74 1.00 0.98 0.63
Data 3 0.63 0.43 0.22 1.00 1.00 0.76 1.00 0.96 0.56 1.00 0.99 0.76 1.00 0.95 0.57
Data 4 0.49 0.40 0.21 1.00 1.00 0.67 1.00 0.99 0.58 1.00 1.00 0.66 1.00 0.97 0.57
Data 5 0.86 0.85 0.66 1.00 1.00 0.90 1.00 1.00 0.87 1.00 1.00 0.89 1.00 0.99 0.87
Data 6 0.87 0.83 0.63 1.00 1.00 0.93 1.00 0.99 0.92 1.00 0.99 0.93 1.00 0.99 0.92nominal signiﬁcance levels 0.01, 0.005, and 0.001. The
power for logistic regression, as well as the empirical power
and exact power for both TS and TSM, are reported in Ta-
ble 4. The results are grouped into two panels with respect
to the two tail-strength measures. Given that bigger ORs
imply a more-signiﬁcant association between factors and
diseases, we would expect to see more small p values in
this situation. So, it is not surprising that the power is
higher when the OR increases from 1.35 to 1.65 in the lo-
gistic-regression model. After we integrated evidence from
the HW-proportion test among case subjects, our approach
for association study gained considerable power compared
to that of the logistic-regression model. For instance, the
observed powers for data set 3 with the use of logistic re-
gression were 63%, 43%, and 22% for the deﬁned signiﬁ-
cance levels 0.01, 0.005, and 0.001, respectively. When
the TS measure was used, the observed empirical powers
were 100%, 100%, and 76% at signiﬁcance levels 0.01,
0.005, and 0.001, respectively; and the observed exact
powers were 100%, 96%, and 56%, respectively. Overall,
the performance of the TSM measure was similar to that
of the TS measure in this model.
Model 2
Tables 5–8 report all the resulting average p values and
powers for the logistic-regression approach,HW-proportion
test among the case group, and empirical and exact tests for
both TS and TSM for both lung-cancer-simulation models.Consider the general model ﬁrst. In this model, the OR
of smoking status is about 10. The average p values are
shown in Table 5. The results are arranged into two panels
with respect to TS and TSM. As expected, we see trends of
decreasing average p values for logistic regression as the
OR increases from 1.35 to 1.65 and as the minor allele fre-
quency increases from 10% to 50%. For example, a dataset
was generated under the scenario of OR ¼ 1.65 and geno-
type frequencies of 81%, 18%, and 1%. On the basis of 100
replicates, and under the alternative hypothesis of an asso-
ciation existing between the SNP and lung cancer, the
average p value obtained from logistic regression analysis
was 0.0069, and the average p value for the HW-proportion
test among case subjects was 0.0278. For both TS and TSM,
the average empirical p value for this scenario, based on
100,000 permutations, was 0.0005, and the average exact
p value calculated from the exact formula was 0.0007.
Even when the logistic p values were already highly signif-
icant, our approach still provided similarly signiﬁcant em-
pirical and exact p values. For example, the logistic p value
of the data set generated with OR ¼ 1.65 and allele fre-
quencies 25%, 50%, and 25% was 0.0002, and the empiri-
cal and exact p values were 0.0003 and 0.0002 for both
measures, respectively. The results demonstrate that our
approach achieves more-signiﬁcant p values by integrating
the evidence from the HW-proportion test in the case
group and that from association from traditional logistic
regression with cases and controls used.Table 5. Average p Values from Different Tests in Simulations for the General Model
Data Sets p-logita p-HWPb
TS TSM
Empirical TS p Values Exact TS p Values Empirical TSM p Values Exact TSM p Values
b ¼ 0.3 (OR ¼ 1.35)
(0.81, 0.18, 0.01) 0.0135 0.0287 0.0008 0.0012 0.0009 0.0013
(0.49, 0.42, 0.09) 0.0079 0.0247 0.0006 0.0007 0.0006 0.0007
(0.25, 0.50, 0.25) 0.0057 0.0272 0.0006 0.0007 0.0006 0.0006
b ¼ 0.5 (OR ¼ 1.65)
(0.81, 0.18, 0.01) 0.0069 0.0278 0.0005 0.0007 0.0005 0.0007
(0.49, 0.42, 0.09) 0.0005 0.0251 0.0003 0.0003 0.0002 0.0003
(0.25, 0.50, 0.25) 0.0002 0.0241 0.0003 0.0003 0.0002 0.0002
a p value from logistic-regression test.
b p value from HW-proportion test.The American Journal of Human Genetics 83, 53–63, July 2008 57
Table 6. Power Comparison at 0.01, 0.005, and 0.001 Significance Levels in Simulations for the General Model
Power for Logistic Model
Power for TS Power for TSM
Empirical Powers Exact Powers Empirical Powers Exact Powers
Data Sets 0.01 0.005 0.001 0.01 0.005 0.001 0.01 0.005 0.001 0.01 0.005 0.001 0.01 0.005 0.001
b ¼ 0.3 (OR ¼ 1.35)
(0.81, 0.18, 0.01) 0.47 0.41 0.17 1.00 1.00 0.74 1.00 0.97 0.60 1.00 0.99 0.72 1.00 0.97 0.58
(0.49, 0.42, 0.09) 0.72 0.61 0.39 1.00 1.00 0.85 1.00 0.98 0.81 1.00 0.98 0.84 1.00 0.98 0.80
(0.25, 0.50, 0.25) 0.83 0.75 0.50 1.00 1.00 0.83 1.00 0.99 0.83 1.00 0.99 0.83 1.00 0.99 0.83
b ¼ 0.5 (OR ¼ 1.65)
(0.81, 0.18, 0.01) 0.76 0.67 0.47 1.00 1.00 0.87 1.00 1.00 0.76 1.00 1.00 0.87 1.00 0.99 0.76
(0.49, 0.42, 0.09) 0.98 0.98 0.94 1.00 1.00 0.99 1.00 1.00 0.99 1.00 1.00 0.99 1.00 1.00 0.99
(0.25, 0.50, 0.25) 1.00 1.00 0.96 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00Table 6 gives the corresponding power-comparison re-
sults at the nominal signiﬁcance levels 0.01, 0.005, and
0.001. Two panels with respect to TS and TSM are shown
in the table. Our approach resulted in much-higher power
than did the logistic-regression approach. All the empirical
powers and exact powers were close to 100% at signiﬁ-
cance levels 0.01 and 0.005 and were much higher at level
0.001 as compared to those from logistic regression. Even
for the data set generated with OR¼ 1.65 and genotype fre-
quencies 25%, 50%, and 25%, which might be considered
to already have enough power with the use of logistic re-
gression, we still saw an increase in the power from 96%
to 100% at signiﬁcance level 0.001. In addition to the re-
sults shown in Tables 5 and 6, we also studied the scenarios
using OR ¼ 2.01 (coefﬁcient of logistic model ¼ 0.7). Sim-
ilar results were obtained. For example, when the genotype
frequencies 81%, 18%, and 1% and OR ¼ 2.01 were as-
sumed, the observed powers for logistic regression were
93%, 91%, and 77% for signiﬁcance levels 0.01, 0.005,
and 0.001, respectively. For both the proposed measures,
the empirical powers and exact powers were approxi-
mately 100% at levels 0.01 and 0.005 and about 95% at
level 0.001, based on 100 replicates. Like the results for
Model 1, the TSM measure had results similar to those of
the TS measure, which is also shown in Tables 5 and 6.58 The American Journal of Human Genetics 83, 53–63, July 2008The average p values and power-comparison results for
the current-smoker model are reported in Tables 7 and 8.
It is not surprising that more signiﬁcant average p values
for logistic regression are seen compared to those in the
general model, because the most-signiﬁcant risk factor
for lung cancer, smoking status, was missing from this
model. We see expected trends in average p values and
power comparisons for both TS and TSM measures in the
current-smoker model, which are similar to those de-
scribed in the general model above. To conclude, the pro-
posed approach performed better than did traditional lo-
gistic regression with the use of the simulated data from
lung-cancer models.
Type I Error Estimate
To evaluate whether our approach can effectively control
the type I error probability, we used only the signiﬁcance
determined by the exact p values for bothmeasures. Table 9
reports the observed type I error rates at the deﬁned sig-
niﬁcances of 0.05, 0.01, 0.005, and 0.001 for all the data
sets based on 10,000 replicates. The results are organized
into three groups with respect to the logistic model, TS,
and TSM. For example, data set 1 in Model 1 was generated
with b0 ¼ 2.0, b1 ¼ 0, and b2 ¼ 0.3, and SNP X2 was ob-
served. When the nominal signiﬁcance level was 0.05,Table 7. Average p Values from Different Tests in Simulations for Current-Smoker Model
Data Sets p-logita p-HWPb
TS TSM
Empirical TS p Values Exact TS p Values Empirical TSM p Values Exact TSM p Values
b ¼ 0.3 (OR ¼ 1.35)
(0.81, 0.18, 0.01) 0.0124 0.0274 0.0007 0.0011 0.0008 0.0011
(0.49, 0.42, 0.09) 0.0049 0.0228 0.0004 0.0005 0.0004 0.0005
(0.25, 0.50, 0.25) 0.0058 0.0242 0.0005 0.0005 0.0005 0.0005
b ¼ 0.5 (OR ¼ 1.65)
(0.81, 0.18, 0.01) 0.0049 0.0255 0.0003 0.0005 0.0003 0.0005
(0.49, 0.42, 0.09) 0.0007 0.0251 0.0003 0.0003 0.0003 0.0003
(0.25, 0.50, 0.25) 0.0001 0.0263 0.0003 0.0003 0.0002 0.0003
a p value from logistic-regression test.
b p value from HW-proportion test.
Table 8. Power Comparison at 0.01, 0.005, and 0.001 Significance Levels in Simulations for Current-Smoker Model
Power for Logistic Model
Power for TS Power for TSM
Empirical Powers Exact Powers Empirical Powers Exact Powers
Data Sets 0.01 0.005 0.001 0.01 0.005 0.001 0.01 0.005 0.001 0.01 0.005 0.001 0.01 0.005 0.001
b ¼ 0.3 (OR ¼ 1.35)
(0.81, 0.18, 0.01) 0.57 0.46 0.20 1.00 1.00 0.78 1.00 0.99 0.61 1.00 1.00 0.76 1.00 0.96 0.61
(0.49, 0.42, 0.09) 0.89 0.69 0.49 1.00 0.99 0.93 1.00 0.99 0.90 1.00 0.99 0.92 1.00 0.99 0.91
(0.25, 0.50, 0.25) 0.80 0.74 0.51 1.00 1.00 0.91 1.00 1.00 0.88 1.00 1.00 0.91 1.00 1.00 0.90
b ¼ 0.5 (OR ¼ 1.65)
(0.81, 0.18, 0.01) 0.83 0.79 0.55 1.00 1.00 0.87 1.00 0.99 0.76 1.00 1.00 0.96 1.00 0.99 0.89
(0.49, 0.42, 0.09) 0.98 0.98 0.92 1.00 1.00 0.99 1.00 1.00 0.99 1.00 1.00 0.99 1.00 1.00 0.99
(0.25, 0.50, 0.25) 1.00 0.99 0.99 1.00 1.00 0.99 1.00 1.00 0.99 1.00 1.00 0.99 1.00 1.00 0.99based on 10,000 replicates, the null hypothesis was re-
jected 505 times for the logistic-regression model, 391
times for the exact method of TS, and 394 times for the ex-
act method of TSM. The corresponding type I error proba-
bilities were 0.0505, 0.0391, and 0.0394, which agree well
with the nominal value of 0.05. In most situations, as com-
pared to the error rates for the logistic model, the type I
error rates were better for the exact methods of both
measures. Therefore, our approach conserves good control
over type I error.
Application to Real Diseases
We next applied our approach to the case-control associa-
tion studies of two different diseases: prostate cancer (PC
[MIM 176807]) and squamous cell carcinoma of head
and neck (SCCHN [MIM 275355]). Because our approach
has exact formulas and the exact p values were considered
satisfactory throughout the simulation studies, we calcu-
lated only the exact p values for both TS and TSM by using
Equations (4) and (7). In order to calculate TS and TSM, we
used the p values obtained from regression-based methods
and calculated the p values of the HW-proportion devia-tion in cases by using the genotype samples provided by
the cancer studies used. In this section, we assessed the
deviation from HW proportion by using the exact test, as
before.
Prostate Cancer
The ﬁrst example of prostate cancer used the results from
a case-control study of 1012 men,29 which investigated
the role of toll-like receptor 4 (TLR4 [MIM 603030]) in
prostate-cancer susceptibility. The authors identiﬁed six
SNPs that comprehensively captured the common genetic
variation of the locus and tested them in 506 cases and 506
controls. Our aim was to evaluate the performance of the
proposed approach with real data. Therefore, for the pur-
pose of simpliﬁcation, we selected only one disease-related
SNP, rs10759932, which was themost signiﬁcant SNP asso-
ciated with prostate cancer in that study.
For this study, the p value provided by the Cheng et al.
paper,29 the p value for the HW-proportion deviation in
cases, and the exact p values of TS and TSM are reported
in the upper panel of Table 10. The p value for association
of the SNP rs10759932 with prostate cancer was 0.006.29
The p value for the HW proportion was 0.0241. The exactTable 9. Estimated Type I Error Probability at 0.05, 0.01, 0.005, and 0.001 Significance Levels in Simulation Studies
Model Data Sets
Type I Error Probability
Logistic Model Exact TS Exact TSM
0.05 0.01 0.005 0.001 0.05 0.01 0.005 0.001 0.05 0.01 0.005 0.001
1 Data 1 0.0505 0.0108 0.0058 0.0010 0.0391 0.0069 0.0034 0.0009 0.0394 0.0068 0.0032 0.0009
1 Data 2 0.0519 0.0094 0.0051 0.0008 0.0391 0.0083 0.0048 0.0008 0.0388 0.0083 0.0046 0.0008
1 Data 3 0.0452 0.0091 0.0044 0.0009 0.0373 0.0065 0.0035 0.0002 0.0369 0.0067 0.0033 0.0002
1 Data 4 0.0457 0.0083 0.0042 0.0005 0.0371 0.0072 0.0037 0.0003 0.0377 0.0068 0.0039 0.0003
2 General Lung-Cancer Population
2 (0.81, 0.18, 0.01) 0.0546 0.0104 0.0058 0.0013 0.0402 0.0072 0.0029 0.0006 0.0397 0.0073 0.0029 0.0006
2 (0.49, 0.42, 0.09) 0.0520 0.0107 0.0058 0.0011 0.0453 0.0088 0.0039 0.0006 0.0451 0.0088 0.0037 0.0006
2 (0.25, 0.50, 0.25) 0.0537 0.0106 0.0049 0.0013 0.0418 0.0092 0.0050 0.0013 0.0406 0.0095 0.0049 0.0012
2 Current-Smoker Lung-Cancer Population
2 (0.81, 0.18, 0.01) 0.0549 0.0103 0.0051 0.0010 0.0368 0.0075 0.0040 0.0008 0.0375 0.0075 0.0040 0.0010
2 (0.49, 0.42, 0.09) 0.0498 0.0096 0.0048 0.0002 0.0448 0.0092 0.0053 0.0006 0.0440 0.0093 0.0052 0.0006
2 (0.25, 0.50, 0.25) 0.0491 0.0104 0.0057 0.0011 0.0514 0.0094 0.0046 0.0009 0.0513 0.0094 0.0045 0.0009The American Journal of Human Genetics 83, 53–63, July 2008 59
Table 10. p Values from Real-Disease Examples
Disease SNP Genotype Cases Controls p Value p-HWPa Exact TS p Values Exact TSM p Values
Prostate Cancer rs10759932 TT 370 358 6.00E-03 2.41E-02 4.33E-04 4.35E-04
CT 117 143
CC 19 4
Head and Neck Cancer A1298C AA 328 274 4.00E-04 7.89E-04 8.41E-07 9.01E-07
AC 199 240
CC 10 31
ACþCC 209 271
a p value from HW-proportion test.p values for TS and TSM were 0.000433 and 0.000435,
which are more signiﬁcant than the p value reported in
the paper.
Head and Neck Cancer
The second example of head and neck cancer was from the
study of Neumann et al.,30 which is a hospital-based case-
control association study involving 537 cases and 545
controls. They found that the methylenetetrahydrofolate
reductase (MTHFR [MIM 607093]) 1298AC/CC genotypes
(rs1801131)were associatedwith an approximately 35% re-
duction in the risk of squamous cell carcinoma of the head
and neck compared to the AA genotype. We used this pro-
tective polymorphism A1298C as another example (in the
previous example, the SNP was a risk factor). We calculated
the p value by using the two-sided Fisher’s exact test, based
on the genotypes in cases and controls given in the paper.
The lower panel of Table 10 shows the p value from the
Fisher’s exact test, the p value for the HW-proportion devi-
ation in cases, and exact p values ofTS andTSM for the head
and neck cancer study. The p value calculated from the
Fisher’s exact test was 0.0004 (OR ¼ 0.64). The p value of
the HW-proportion test in cases was 0.000789, with the ex-
act test used. And, the exact p valueswere 0.000000841 and
0.000000901 for TS and TSM, respectively, which were,
once again,more signiﬁcant than that reported in the study.
Compared to the p values obtained by the use of tradi-
tional regression-based approaches of genetic-association
study, signiﬁcantly smaller p values were achieved with
our approach for both real-data examples. TS and TSM per-
formed similarly, as before, and worked well for both risk
and protective SNPs.
Discussion
Traditional approaches to the assessment of genetic asso-
ciation between SNPs and disease status are the logistic-
regression model and the generalized linear model. Re-
searchers have suggested that the deviation of genotype
frequencies from HW proportion among cases can provide
additional evidence for a real association between diseases
and SNPs. In this paper, we have shown that this is indeed
the case.
Here, we have proposed an approach to the performance
of genetic-association studies between disease outcomes60 The American Journal of Human Genetics 83, 53–63, July 2008and SNPs with the use of case-control data. This approach
uses the mean-based tail-strength measure to take into
account the signiﬁcance of the logistic-regression model
using case and control data simultaneously with depar-
tures from HW proportion in the case group. The tail-
strength measure is a linear combination of the difference
between ranked and expected p values. Inmany situations,
median-based estimators might be more robust, especially
for extreme observations. Therefore, we developed a mea-
sure for assessing tail strength with the use of median
values, which we call the tail-strength-median (TSM) mea-
sure. Both measures have a close relationship to the FDR
approach to multiple-hypothesis testing. We have derived
exact formulas for the calculation of p values for both
measures. In addition, we have proposed an approach for
evaluating empirical p values with the use of a resampling
procedure.
We conducted simulation studies of two different logis-
tic models to illustrate the performance of our approach.
The ﬁrst simulation model (Model 1) had SNPs as the
only risk factors of disease. The other simulation model
(Model 2) included two revised lung-cancer models (the
model of the general population and that of the current-
smoker population) based on a real lung-cancer study.23
Various ORs and genotype frequencies were studied in
Model 2. Our approach worked well in both models. The
resulting average exact p values and empirical p values
from both measures were more signiﬁcant than the tradi-
tional logistic p values. When the logistic p values were
already very signiﬁcant, our approach still obtained com-
parable empirical and exact p values. Power-comparison
results showed that the tail strength measure added signif-
icant power to the traditional logistic-regression model for
genetic-association study by integrating evidence from
HW-proportion deviation in the case group with associa-
tion from traditional regression approaches. Further simu-
lation was performed to show that our approach can effec-
tively control the type I error probabilities.
Twodisease-relatedSNPswereusedas examplesof realdis-
eases todemonstrate theperformanceofourapproach.One,
SNP rs10759932, is associated with prostate cancer; the
other, MTHFR polymorphism A1298C, is associated with
head and neck cancer. The p values obtained from the liter-
atures were used for the purpose of comparison. Our ap-
proach performed very well in all scenarios studied. Our
approach is also applicable to other statistical tests that
could be considered for association studies in the literature,
including piecewise logistic regression,31 nonparametric lo-
gistic regression,32 and functional logistic regression.33
In the present paper, we have considered the association
between one single, independent SNP and the disease in
question. In the future, we would like to extend the idea
proposed in this paper to studies of association between
multiple independent and correlated SNPs and diseases si-
multaneously. In such situations, it might be possible to in-
tegrate the linkage disequilibrium among SNPs, which are
close to each other as well.
Appendix 1
Derivations for the Density Functions of TS and TSM
Density Function of TS: The original p values are uni-
formly distributed under the null hypothesis; therefore, or-
dered p values p(1) and p(2) follow a beta distribution under
the null hypothesis, and the joint probability distribution
is34 fPð1Þ,Pð2Þ ðpð1Þ, pð2ÞÞ ¼ 2, 0% pð1Þ% pð2Þ%1. Consider the
transformation U ¼ TS ¼ 1 ð3=2ÞPð1Þ  ð3=4ÞPð2Þ and
V ¼ Pð1Þ. So, solving the equations for p(1) and p(2) in terms
of observed values u ¼ 1 ð3=2Þpð1Þ  ð3=4Þpð2Þ and
v ¼ pð1Þ, we get the inverse transformation pð1Þ ¼ v and
pð2Þ ¼ ð4=3Þ  ð4=3Þu 2v. And the Jacobian of the trans-
formation is J ¼ 4=3.
Therefore, the joint probability of U and V is
fU ,Vðu,vÞ ¼ fPð1Þ ,Pð2Þ ðpð1Þ, pð2ÞÞjJj ¼ 8=3. The domain for U
and V can be found accordingly:
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According to the settings of transformation, the density
function of TS is
fTS ¼ fUðuÞ ¼
ð
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Given an observation of TS*, we can calculate the exact
p values of TS:
p value ¼
ð1
TS
fTSðxÞdx
¼

29
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(
Density Function of TSM: Now, consider the trans-
formation U ¼ TSM ¼ 1 ð1þ 1= ﬃﬃﬃ2p ÞPð1Þ  ð1= ﬃﬃﬃ2p ÞPð2Þ
andV ¼ Pð1Þ. Solving the equations for p(1) and p(2) in terms
of observed values u ¼ 1 ð1þ 1= ﬃﬃﬃ2p Þpð1Þ  ð1= ﬃﬃﬃ2p Þpð2Þ andv ¼ pð1Þ, we get the inverse transformation pð1Þ ¼
h1ðu, vÞ ¼ v and pð2Þ ¼ h2ðu, vÞ ¼
ﬃﬃﬃ
2
p  ﬃﬃﬃ2p u ð1þ ﬃﬃﬃ2p Þv.
And the Jacobian of the transformation is J ¼ ﬃﬃﬃ2p .
Therefore, the joint probability of U and V is
fU,V ðu, vÞ ¼ fPð1Þ,Pð2Þ ðpð1Þ, pð2ÞÞjJj ¼ 2
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2
p
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According to the settings of transformation, the density
function of TSM is
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Therefore, given an observation of TSM*, we can calcu-
late the exact p values of random variable TSM:
p value ¼
ð1
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Appendix 2
Permutation Test
To examine the performance of the permutation test used
in this paper, we picked one replicate of data from lung-
cancer-model data sets and plotted the histograms for per-
mutated p values for both logistic regression and HW pro-
portion in cases, as well as the corresponding empirical
and exact TS and TSM values. The example data set was
generated with the use of the general lung-cancer model
with OR for SNP ¼ 1.65 and genotype frequencies of
49%, 42%, and 9%. Figure 1 shows all of the histogramsThe American Journal of Human Genetics 83, 53–63, July 2008 61
(permutated logistic p values, permutated HW-proportion
p values, permutated TS, and permutated TSM) and the
probability-density-function curves of TS and TSM random
variables. The permutation p values of the logistic regres-
sion test and the HW-proportion test in cases are approxi-
mately uniformly distributed. The permutated TS and TSM
values are skewed to the right, which agrees with their ex-
act probability-density-function curves. And, the empirical
distributions are a good ﬁt for the exact distributions for
both measures.
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Web Resources
The URLs for data presented herein are as follows:
Computing program, http://www.epigenetic.org/software.php
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
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